tiprankstipranks
Takeda Pharmaceutical Co Ltd (GB:0RN3)
LSE:0RN3

Takeda Pharmaceutical Co (0RN3) Share Price & Analysis

2 Followers

0RN3 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€35.20 - €35.20
Previous Close€35.2
Volume0.00
Average Volume (3M)N/A
Market Cap
€42.15B
Enterprise Value€3.51T
Total Cash (Recent Filing)$632.70B
Total Debt (Recent Filing)$4.38T
Price to Earnings (P/E)52.9
BetaN/A
May 09, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding1,582,408,825
10 Day Avg. Volume369,338
30 Day Avg. VolumeN/A
Standard Deviation0.09
R-Squared0.28
Alpha-0.00192
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit1.34
Enterprise Value/Ebitda3.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%<0.01%100.00%
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

0RN3 FAQ

What was Takeda Pharmaceutical Co Ltd’s price range in the past 12 months?
Takeda Pharmaceutical Co Ltd lowest share price was €35.20 and its highest was €35.20 in the past 12 months.
    What is Takeda Pharmaceutical Co Ltd’s market cap?
    Currently, no data Available
    When is Takeda Pharmaceutical Co Ltd’s upcoming earnings report date?
    Takeda Pharmaceutical Co Ltd’s upcoming earnings report date is May 09, 2024 which is in 42 days.
      How were Takeda Pharmaceutical Co Ltd’s earnings last quarter?
      Takeda Pharmaceutical Co Ltd released its earnings results on Feb 01, 2024. The company reported €0.421 earnings per share for the quarter, beating the consensus estimate of N/A by €0.421.
        Is Takeda Pharmaceutical Co Ltd overvalued?
        According to Wall Street analysts Takeda Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Takeda Pharmaceutical Co Ltd pay dividends?
          Takeda Pharmaceutical Co Ltd pays a Semiannually dividend of €0.58 which represents an annual dividend yield of 4.6%. See more information on Takeda Pharmaceutical Co Ltd dividends here
            What is Takeda Pharmaceutical Co Ltd’s EPS estimate?
            Takeda Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Takeda Pharmaceutical Co Ltd have?
            Takeda Pharmaceutical Co Ltd has 1,582,408,800 shares outstanding.
              What happened to Takeda Pharmaceutical Co Ltd’s price movement after its last earnings report?
              Takeda Pharmaceutical Co Ltd reported an EPS of €0.421 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Takeda Pharmaceutical Co Ltd?
                Currently, no hedge funds are holding shares in GB:0RN3
                ---

                Takeda Pharmaceutical Co Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -11.51%
                12-Months-Change

                Fundamentals

                Return on Equity
                2.68%
                Trailing 12-Months
                Asset Growth
                -1.43%
                Trailing 12-Months

                Company Description

                Takeda Pharmaceutical Co Ltd

                Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Roche Holding
                Sanofi
                GlaxoSmithKline
                AstraZeneca
                Takeda Pharmaceutical Co
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis